Items tagged with Vaccines
Global Forum on TB Vaccines 2021: Meeting report (post)
The Global Forum on TB Vaccines was held virtually on 20-22 April 2021, marking its 20th anniversary. The Global Forum on TB Vaccines is the world's largest gathering of stakeholders striving to develop new vaccines to prevent TB.
BCG: the history and modern-day uses of the TB vaccine (post)
In 1921, the Bacillus Calmette-Guérin (BCG) tuberculosis vaccine was first administered to a human. The vaccine was developed by French scientists Albert Calmette and Camille Guérin to protect against tuberculosis of the lungs, a leading cause of death in the early 1900s.
STriTuVaD clinical trial of RUTI® vaccine for TB: First patient recruited at AIIMS, India (post)
The STriTuVaD Consortium is proud to announce the recruitment of the first patient in the STriTuVaD clinical trial of RUTI® vaccine for tuberculosis (TB)
The COVID pandemic must lead to TB vaccines (post)
The coronavirus crisis has halted decades of progress on TB. But the speed of COVID vaccines shows there can still be hope for advances against neglected diseases.
Registration for the 6th Global Forum on TB Vaccines is now open (post)
The 6th Global Forum on TB Vaccines will be held on 22-24 February 2022 as a hybrid event, with options for in-person and virtual participation.
Team studies how existing BCG vaccination could serve as foundation for new, more effective TB vaccines (post)
A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering. And yet TB still kills around 1.5 million people every year. The problem is that the BCG vaccine was the first—and the last—vaccine approved to prevent tuberculosis.
6th Global Forum on TB Vaccines: Participant support application deadline (post)
The 6th Global Forum on TB Vaccines will be held on 22-24 February 2022 as a hybrid event, with options for in-person and virtual participation.
TB vaccine advocacy social media fellowship (post)
The International AIDS Vaccine Initiative (IAVI) announced a social media fellowship starting the last week of January 2022.
TB vaccine could assist future COVID-19 vaccine development (post)
Despite unprecedented efforts to develop COVID-19 vaccines in record time amid the global pandemic, SARS-CoV-2 continues to spread rapidly with the emergence of new variants, such as delta and omicron, making the development of new therapeutic strategies critically important.
Computational models move researchers closer to TB vaccine (post)
According to a 2021 World Health Organization report, the global COVID-19 pandemic caused an increase in tuberculosis (TB) deaths – 1.5 million in 2020 versus 1.4 million in 2019 – due to a lack of efficient diagnosis and treatment. Since TB has been the number one cause of death from infectious disease in the world for centuries, University of Michigan (UM) Medical School Professor Denise Kirschner and colleagues have been working to better understand the disease by using supercomputers like Expanse at the San Diego Supercomputer Center at UC San Diego.
Page 18 of 32 · Total posts: 0
←First 17 18 19 Last→